These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 23483312)

  • 61. Expression of the VP1 protein of FMDV integrated chromosomally with mutant Listeria monocytogenes strain induced both humoral and cellular immune responses.
    Mahdy SE; Liu S; Su L; Zhang X; Chen H; Pei X; Wang C
    Appl Microbiol Biotechnol; 2019 Feb; 103(4):1919-1929. PubMed ID: 30627793
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Immune Responses to Orally Administered Recombinant
    Zhang F; Zhang Z; Li X; Li J; Lv J; Ma Z; Pan L
    Viruses; 2021 Oct; 13(10):. PubMed ID: 34696469
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Immune responses to the oral administration of recombinant Bacillus subtilis expressing multi-epitopes of foot-and-mouth disease virus and a cholera toxin B subunit.
    Hu B; Li C; Lu H; Zhu Z; Du S; Ye M; Tan L; Ren D; Han J; Kan S; Wang J; Jin N
    J Virol Methods; 2011 Jan; 171(1):272-9. PubMed ID: 21129406
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Increasing a robust antigen-specific cytotoxic T lymphocyte response by FMDV DNA vaccination with IL-9 expressing construct.
    Zou Q; Wu B; He X; Zhang Y; Kang Y; Jin J; Xu H; Liu H; Wang B
    J Biomed Biotechnol; 2010; 2010():562356. PubMed ID: 20445754
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Using Self-Assembling ADDomer Platform to Display B and T Epitopes of Type O Foot-and-Mouth Disease Virus.
    Luo C; Yan Q; Huang J; Liu J; Li Y; Wu K; Li B; Zhao M; Fan S; Ding H; Chen J
    Viruses; 2022 Aug; 14(8):. PubMed ID: 36016432
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Induction of mucosal immune responses and protection of cattle against direct-contact challenge by intranasal delivery with foot-and-mouth disease virus antigen mediated by nanoparticles.
    Pan L; Zhang Z; Lv J; Zhou P; Hu W; Fang Y; Chen H; Liu X; Shao J; Zhao F; Ding Y; Lin T; Chang H; Zhang J; Zhang Y; Wang Y
    Int J Nanomedicine; 2014; 9():5603-18. PubMed ID: 25506214
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Induction of protective immunity in swine by recombinant bamboo mosaic virus expressing foot-and-mouth disease virus epitopes.
    Yang CD; Liao JT; Lai CY; Jong MH; Liang CM; Lin YL; Lin NS; Hsu YH; Liang SM
    BMC Biotechnol; 2007 Sep; 7():62. PubMed ID: 17900346
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Virus-like particle-based multipathogen vaccine of FMD and SVA elicits balanced and broad protective efficacy in mice and pigs.
    Song H; Waheed Abdullah S; Yin S; Dong H; Zhang Y; Tan S; Bai M; Ding Y; Teng Z; Sun S; Guo H
    Vaccine; 2024 Jul; 42(18):3789-3801. PubMed ID: 38714448
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Adenovirus-vectored foot-and-mouth disease vaccine confers early and full protection against FMDV O1 Manisa in swine.
    Fernandez-Sainz I; Medina GN; Ramirez-Medina E; Koster MJ; Grubman MJ; de Los Santos T
    Virology; 2017 Feb; 502():123-132. PubMed ID: 28039799
    [TBL] [Abstract][Full Text] [Related]  

  • 70. An approach to a FMD vaccine based on genetic engineered attenuated pseudorabies virus: one experiment using VP1 gene alone generates an antibody responds on FMD and pseudorabies in swine.
    Qian P; Li XM; Jin ML; Peng GQ; Chen HC
    Vaccine; 2004 Jun; 22(17-18):2129-36. PubMed ID: 15149769
    [TBL] [Abstract][Full Text] [Related]  

  • 71. An MHC-restricted CD8+ T-cell response is induced in cattle by foot-and-mouth disease virus (FMDV) infection and also following vaccination with inactivated FMDV.
    Guzman E; Taylor G; Charleston B; Skinner MA; Ellis SA
    J Gen Virol; 2008 Mar; 89(Pt 3):667-675. PubMed ID: 18272757
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Recombinant adenovirus co-expressing capsid proteins of two serotypes of foot-and-mouth disease virus (FMDV): in vitro characterization and induction of neutralizing antibodies against FMDV in swine.
    Wu Q; Moraes MP; Grubman MJ
    Virus Res; 2003 Jun; 93(2):211-9. PubMed ID: 12782369
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Delivery of synthetic RNA can enhance the immunogenicity of vaccines against foot-and-mouth disease virus (FMDV) in mice.
    Borrego B; Rodríguez-Pulido M; Mateos F; de la Losa N; Sobrino F; Sáiz M
    Vaccine; 2013 Sep; 31(40):4375-81. PubMed ID: 23859841
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Immunization of DNA vaccine encoding C3d-VP1 fusion enhanced protective immune response against foot-and-mouth disease virus.
    Fan H; Tong T; Chen H; Guo A
    Virus Genes; 2007 Oct; 35(2):347-57. PubMed ID: 17497212
    [TBL] [Abstract][Full Text] [Related]  

  • 75. A foot-and-mouth disease SAT2 vaccine protects swine against experimental challenge with a homologous virus strain, irrespective of mild pathogenicity in this species.
    Mouton L; Dekker A; Bleijenberg M; Blanchet M; Coco-Martin J; Hudelet P; Goutebroze S
    Vaccine; 2018 Apr; 36(15):2020-2024. PubMed ID: 29510916
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Immunogenicity of plasmids encoding P12A and 3C of FMDV and swine IL-18.
    Mingxiao M; Ningyi J; Juan LH; Min Z; Guoshun S; Guangze Z; Huijun L; Xiaowei H; Minglan J; Xu L; Haili M; Yue J; Gefen Y; Kuoshi J
    Antiviral Res; 2007 Oct; 76(1):59-67. PubMed ID: 17606304
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Ginseng stem-leaf saponins (GSLS) and mineral oil act synergistically to enhance the immune responses to vaccination against foot-and-mouth disease in mice.
    Song X; Bao S; Wu L; Hu S
    Vaccine; 2009 Jan; 27(1):51-5. PubMed ID: 18973783
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Rapid Engineering of Foot-and-Mouth Disease Vaccine and Challenge Viruses.
    Lee SY; Lee YJ; Kim RH; Park JN; Park ME; Ko MK; Choi JH; Chu JQ; Lee KN; Kim SM; Tark D; Lee HS; Ko YJ; Seo MG; Park JW; Kim B; Lee MH; Lee JS; Park JH
    J Virol; 2017 Aug; 91(16):. PubMed ID: 28566375
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Immune Response and Partial Protection against Heterologous Foot-and-Mouth Disease Virus Induced by Dendrimer Peptides in Cattle.
    Soria I; Quattrocchi V; Langellotti C; Pérez-Filgueira M; Pega J; Gnazzo V; Romera S; Schammas J; Bucafusco D; Di Giacomo S; de la Torre BG; Andreu D; Sobrino F; Blanco E; Zamorano P
    J Immunol Res; 2018; 2018():3497401. PubMed ID: 29854834
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Evaluation of a genetically modified foot-and-mouth disease virus vaccine candidate generated by reverse genetics.
    Li P; Bai X; Sun P; Li D; Lu Z; Cao Y; Fu Y; Bao H; Chen Y; Xie B; Liu Z
    BMC Vet Res; 2012 May; 8():57. PubMed ID: 22591597
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.